PEPG: PepGen Inc Book Value of Business

Public company logo of PepGen Corp (PEPG)

The PepGen Inc. (PEPG) price chart illustrates the dynamics of an asset whose business focuses on creating advanced therapies for Duchenne muscular dystrophy using the EDO system for drug delivery to the heart and muscles. The company's revenues will depend on the implementation of gene therapy and the sale of drugs against myotonic dystrophy. Currently, the R&D center is actively preparing Phase 2 trial data, and the metric stands at 0.12.

PEPG PepGen Corp Book Capitalization (04/28/2023 - 10/27/2026)

Metric breakdowns and analytics for PepGen Corp (PEPG)

- price and consensus price forecast:
Quote Chart PepGen Inc.|PEPG - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization PepGen Inc|PEPG - Total Company Value
- book capitalization data:
Equity per Share PepGen|PEPG - Book Capitalization|Market-to-Book Ratio pepgen.com|PEPG - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital PepGen Inc.|PEPG - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital PepGen Inc.|PEPG - Company Debts|Debts to Book Value PepGen Inc
Summary company analysis:PepGen - PEPG
Flagship merchandise of pepgen.com

To identify the fundamental drivers of stability for PepGen Inc. (PEPG), it is essential to evaluate net assets minus all liabilities, which reflects the real value of the business regardless of market volatility. Analyzing the history of net assets at book value reveals whether the company possesses sufficient resources to scale clinical trials for its EDO platform and capture the neuropharmaceuticals segment.

Analysis of competing companies

BIIB - Net Asset Value|Book Capitalization NBIX (Neurocrine Biosciences)|RGC (regencellbioscience.com) - Book Value of Business|Company Book Value Axsome Therapeutics, Inc. (AXSM)|Accounting Capitalization ACADIA Pharma|Xenon Pharmaceuticals Inc - Book Capitalization|Total Stockholders' Equity Viking Therapeutics Corp VKTX|Company Net Assets SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Book Capitalization|Company Book Value Denali Therapeutics Inc. (DNLI)|HRMY: Accounting Value of Company|Company Book Value BHVN|AMLX (Amylyx Corp) - Total Stockholders' Equity|Company Book Value Trevi Therapeutics TRVI|Net Asset Value praxismedicines.com|Anavex Life Sciences Corp. - Book Capitalization|Total Stockholders' Equity CBLL (CeriBell Inc)|prothena.com (PRTA) - Company Book Value|Net Asset Value Alector Inc. ALEC|Book Capitalization ANNX|OMER - Book Value of Business|Book Capitalization NGNE|ACIU (AC Immune S.A.) - Total Stockholders' Equity|Company Book Value Voyager Pharma (VYGR)|Accounting Capitalization Neumora Corp (NMRA)|Scilex Holding Company (SCLX) - Company Net Assets|Accounting Value of Company tevogen.com (TVGN)|Book Capitalization ACOG|cogrx.com - Book Valuation of Business|Inhibikase (IKT) - Company Book Value|SAVA - Accounting Capitalization|ASRT (assertiotx.com) - Book Capitalization|Company Net Assets Coya Therapeutics|VTGN: Company Net Assets|Book Valuation of Business OVID|ABOS - Company Book Value|Net Asset Value CervoMed Corporation (CRVO)|ATHE: Book Capitalization|Clene Inc - Total Stockholders' Equity|Company Book Value Jupiter Neurosciences Inc|RLMD - Net Asset Value|Book Capitalization ANVS (Annovis Bio Corp)|GRCE (Grace Therapeutics) - Book Value of Business|Company Book Value Firefly Neuroscience, Inc (AIFF)|Accounting Capitalization ANEW Medical, Inc.|NeuroSense Therapeutics - Book Capitalization|Total Stockholders' Equity Reviva Pharmaceuticals Holdings Inc. RVPH|Company Net Assets MTVA (MetaVia)|NeurAxis Inc - Book Capitalization|Company Book Value Helius Medical Technologies Inc. (HSDT)|PASG: Accounting Value of Company|Company Book Value NEUP|NERV (Minerva Neurosciences Inc) - Total Stockholders' Equity|Company Book Value Athira ATHA|Net Asset Value Addex|Alzamend Neuro, Inc. - Book Capitalization|Total Stockholders' Equity CYCN (cyclerion.com)|Protagenic Therapeutics, Inc. (PTIX) - Company Book Value|Net Asset Value Pasithea Therapeutics Corp KTTA|Book Capitalization CRGT|ATXI - Book Value of Business|Book Capitalization BCLI|CARA (caratherapeutics.com) - Total Stockholders' Equity|Company Book Value Chromocell Therapeutics Corp. (CHRO)|Accounting Capitalization Eliem (ELYM)|Intra-Cellular Therapies (ITCI) - Company Net Assets|Accounting Value of Company Longboard (LBPH)|Book Capitalization MRNS|nkgenbiotech.com - Book Valuation of Business|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Book Value|SAGE - Accounting Capitalization|SNPX (Neurotrope) - Book Capitalization|Company Net Assets Trevena Inc|VIGL: Company Net Assets|Book Valuation of Business WENA|CERE - Company Book Value